Comparable stake leader
Column Group IV GP, LP
SEC ownership of Eikon Therapeutics, Inc.
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001861123.
Disclosed value leader
Column Group IV GP, LP
Comparable rows
50/50
Latest evidence
30 Jun 2026
- Public ticker
- EIKN on Nasdaq
- Parsed ownership sources
-
13D/G, 3/4/5, and 13F
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
Column Group IV GP, LP
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
50 of 50
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
Column Group IV GP, LP
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
30 Jun 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001861123
- Issuer location
- Millbrae, CA
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Eikon Therapeutics, Inc. (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Column Group IV GP, LP
Disclosed value leader
Column Group IV GP, LP
Comparable rows
50/50
Latest evidence
30 Jun 2026
13D/G
3/4/5
13F
Lead comparable stake: 12%
13D/G row: Column Group IV GP, LP
Showing 1-8 of 50 holder rows.
Quick read
Column Group IV GP, LP leads the comparable SEC ownership view at 12%.
50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Column Group IV GP, LP's linked filing trail.
Comparable ownership
Top 5
Column Group IV GP, LP
12%
FMR LLC
9.2%
Foresite Capital Fund IV, L.P.
7.7%
BlackRock Portfolio Management LLC
5.5%
Roger M. Perlmutter
5.2%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Column Group IV GP, LP |
13D/G
3/4/5
Tim Kutzkey · 10%+ Owner
|
12%
|
$131,204,153
6,353,712 shares
|
$0 | 06 Feb 2026 |
| FMR LLC |
13F
13D/G
Company
|
9.2%
from 13D/G
|
$65,179,504
4,994,254 shares
mixed-class rows
|
— | 30 Jun 2026 |
| Foresite Capital Fund IV, L.P. |
13D/G
James B. Tananbaum
|
7.7%
|
—
4,148,519 shares
|
$0 | 04 Feb 2026 |
| BlackRock Portfolio Management LLC |
13D/G
|
5.5%
|
$29,456,850
3,002,737 shares
|
$0 | 31 Mar 2026 |
| Roger M. Perlmutter |
13D/G
3/4/5
PERLMUTTER ROGER M · Chief Executive Officer and Director, Director
|
5.2%
|
$28,555,598
2,893,171 shares
|
$0 | 04 Feb 2026 |
| Abu Dhabi Investment Authority |
13D/G
|
5.2%
|
—
2,816,714 shares
|
$0 | 04 Feb 2026 |
| Innovation Endeavors III LP |
13D/G
|
5%
|
$26,878,241
2,723,226 shares
|
$0 | 31 Mar 2026 |
| Boxer Capital Management, LLC |
13F
Company
|
9.2%
|
$26,963,591
1,105,683 shares
|
— | 30 Jun 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 22 Aug 2025.
Buys
$0
Insiders: 0
Sells
$0
Insiders: 0
Net
$0
Shares: 0
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 0
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-14 of 14 reporting-owner rows connected to Eikon Therapeutics, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Rows
14
Largest Forms 3/4/5 holder
Lux Venture Partners V, LLC
Net 12M change
$0
Latest report
15 Jun 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Lux Venture Partners V, LLC | 10%+ Owner | Mixed | 04 Feb 2026 | |||
| Roger M. Perlmutter | Chief Executive Officer and Director, Director | Mixed | 02 Mar 2026 | |||
| Kenneth C. Frazier | Director | Mixed | 02 Mar 2026 | |||
| David W. Meline | Director | Mixed | 04 Feb 2026 | |||
| Roy D. Baynes | Chief Medical Officer | Mixed | 02 Mar 2026 | |||
| Foresite Capital Management IV, LLC | 10%+ Owner | Mixed | 04 Feb 2026 | |||
| Leon Chen | Director | Mixed | 04 Feb 2026 | |||
| Column Group IV GP, LP | 10%+ Owner | Mixed | 06 Feb 2026 | |||
| Robert Luther Huffines | Director | Mixed | 02 Mar 2026 | |||
| Michael A. Klobuchar | Chief Operating Officer | Mixed | 02 Mar 2026 | |||
| Josh Wolfe | Director, 10%+ Owner | Mixed | 04 Feb 2026 | |||
| Benjamin Bruno Thorner | General Counsel and Chief Business Officer | Mixed | 02 Mar 2026 | |||
| Alfred Lloyd Bowie Jr. | Chief Financial Officer | Mixed | 02 Mar 2026 | |||
| Ma. Fatima Francisco | Director | Mixed | 15 Jun 2026 |
Recent insider transactions for Eikon Therapeutics, Inc.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Michael A. Klobuchar | EIKN | Stock Option (Right to Buy) | Award | 87,157 | 87,157 | 02 Mar 2026 | Direct | |||
| Robert Luther Huffines | EIKN | Stock Option (Right to Buy) | Award | 25,873 | 25,873 | 02 Mar 2026 | Direct | |||
| Kenneth C. Frazier | EIKN | Stock Option (Right to Buy) | Award | 25,873 | 25,873 | 02 Mar 2026 | Direct | |||
| Roger M. Perlmutter | EIKN | Stock Option (Right to Buy) | Award | 268,176 | 268,176 | 02 Mar 2026 | Direct | |||
| Benjamin Bruno Thorner | EIKN | Stock Option (Right to Buy) | Award | 67,044 | 67,044 | 02 Mar 2026 | Direct | |||
| Roy D. Baynes | EIKN | Stock Option (Right to Buy) | Award | 134,088 | 134,088 | 02 Mar 2026 | Direct | |||
| Alfred Lloyd Bowie Jr. | EIKN | Stock Option (Right to Buy) | Award | 67,044 | 67,044 | 02 Mar 2026 | Direct | |||
| Roger M. Perlmutter | EIKN | Common Stock | Conversion of derivative security | 284,857 | 284,857 | 06 Feb 2026 | See Footnote | |||
| Roger M. Perlmutter | EIKN | Series D Preferred Stock | Conversion of derivative security | -100% | -855,512 | 0 | 06 Feb 2026 | See Footnote | ||
| Roger M. Perlmutter | EIKN | Series A-1 Preferred Stock | Conversion of derivative security | -100% | -1,268,891 | 0 | 06 Feb 2026 | See Footnote | ||
| Column Group IV GP, LP | EIKN | Common Stock | Purchase | 91.7% | 630,881 | 1,319,164 | 06 Feb 2026 | By The Column Group Opportunity III, LP | ||
| Column Group IV GP, LP | EIKN | Common Stock | Purchase | 49.9% | 49,556 | 148,840 | 06 Feb 2026 | By The Column Group IV-A, LP | ||
| Column Group IV GP, LP | EIKN | Common Stock | Purchase | 50% | 1,437,323 | 4,312,139 | 06 Feb 2026 | By The Column Group IV, LP | ||
| Column Group IV GP, LP | EIKN | Common Stock | Conversion of derivative security | 688,283 | 688,283 | 06 Feb 2026 | By The Column Group Opportunity III, LP | |||
| Column Group IV GP, LP | EIKN | Common Stock | Conversion of derivative security | 2861.9% | 95,932 | 99,284 | 06 Feb 2026 | By The Column Group IV-A, LP | ||
| Column Group IV GP, LP | EIKN | Common Stock | Conversion of derivative security | 4413.7% | 2,811,125 | 2,874,816 | 06 Feb 2026 | By The Column Group IV, LP | ||
| Column Group IV GP, LP | EIKN | Series D Preferred Stock | Conversion of derivative security | -100% | -5,133,076 | 0 | 06 Feb 2026 | By The Column Group Opportunity III, LP | ||
| Column Group IV GP, LP | EIKN | Series C-1 Preferred Stock | Conversion of derivative security | -100% | -28,229 | 0 | 06 Feb 2026 | By The Column Group IV-A, LP | ||
| Column Group IV GP, LP | EIKN | Series C-1 Preferred Stock | Conversion of derivative security | -100% | -827,278 | 0 | 06 Feb 2026 | By The Column Group IV, LP | ||
| Column Group IV GP, LP | EIKN | Series A-1 Preferred Stock | Conversion of derivative security | -100% | -357,216 | 0 | 06 Feb 2026 | By The Column Group IV-A, LP | ||
| Column Group IV GP, LP | EIKN | Series A-1 Preferred Stock | Conversion of derivative security | -100% | -10,467,526 | 0 | 06 Feb 2026 | By The Column Group IV, LP | ||
| Column Group IV GP, LP | EIKN | Series A Preferred Stock | Conversion of derivative security | -100% | -330,000 | 0 | 06 Feb 2026 | By The Column Group IV-A, LP | ||
| Column Group IV GP, LP | EIKN | Series A Preferred Stock | Conversion of derivative security | -100% | -9,670,000 | 0 | 06 Feb 2026 | By The Column Group IV, LP | ||
| Josh Wolfe | EIKN | Common Stock | Conversion of derivative security | 5,695,010 | 2,387,705 | 06 Feb 2026 | See footnote | |||
| Josh Wolfe | EIKN | Series D Preferred Stock | Conversion of derivative security | -100% | -10,266,152 | 0 | 06 Feb 2026 | See footnote | ||
| Josh Wolfe | EIKN | Series C-1 Preferred Stock | Conversion of derivative security | -100% | -1,450,614 | 0 | 06 Feb 2026 | See footnote | ||
| Josh Wolfe | EIKN | Series C Preferred Stock | Conversion of derivative security | -100% | -303,360 | 0 | 06 Feb 2026 | See footnote | ||
| Josh Wolfe | EIKN | Series B-1 Preferred Stock | Conversion of derivative security | -100% | -8,815,537 | 0 | 06 Feb 2026 | See footnote | ||
| Josh Wolfe | EIKN | Series B Preferred Stock | Conversion of derivative security | -100% | -1,327,300 | 0 | 06 Feb 2026 | See footnote | ||
| Josh Wolfe | EIKN | Series A-1 Preferred Stock | Conversion of derivative security | -100% | -10,309,278 | 0 | 06 Feb 2026 | See footnote | ||
| Josh Wolfe | EIKN | Series A Preferred Stock | Conversion of derivative security | -100% | -10,000,000 | 0 | 06 Feb 2026 | See footnote | ||
| Lux Venture Partners V, LLC | EIKN | Common Stock | Conversion of derivative security | 5,695,010 | 2,387,705 | 06 Feb 2026 | See Footnote | |||
| Lux Venture Partners V, LLC | EIKN | Series D Preferred Stock | Conversion of derivative security | -100% | -10,266,152 | 0 | 06 Feb 2026 | See Footnote | ||
| Lux Venture Partners V, LLC | EIKN | Series C-1 Preferred Stock | Conversion of derivative security | -100% | -1,450,614 | 0 | 06 Feb 2026 | See Footnote | ||
| Lux Venture Partners V, LLC | EIKN | Series C Preferred Stock | Conversion of derivative security | -100% | -303,360 | 0 | 06 Feb 2026 | See Footnote | ||
| Lux Venture Partners V, LLC | EIKN | Series B-1 Preferred Stock | Conversion of derivative security | -100% | -8,815,537 | 0 | 06 Feb 2026 | See Footnote | ||
| Lux Venture Partners V, LLC | EIKN | Series B Preferred Stock | Conversion of derivative security | -100% | -1,327,300 | 0 | 06 Feb 2026 | See Footnote | ||
| Lux Venture Partners V, LLC | EIKN | Series A-1 Preferred Stock | Conversion of derivative security | -100% | -10,309,278 | 0 | 06 Feb 2026 | See Footnote | ||
| Lux Venture Partners V, LLC | EIKN | Series A Preferred Stock | Conversion of derivative security | -100% | -10,000,000 | 0 | 06 Feb 2026 | See Footnote | ||
| Foresite Capital Management IV, LLC | EIKN | Common Stock | Purchase | 4.4% | 55,555 | 1,318,983 | 04 Feb 2026 | See Footnote | ||
| Foresite Capital Management IV, LLC | EIKN | Common Stock | Conversion of derivative security | 4,041,687 | 1,943,682 | 04 Feb 2026 | See Footnote | |||
| Foresite Capital Management IV, LLC | EIKN | Series D Preferred Stock | Conversion of derivative security | -100% | -5,133,076 | 0 | 04 Feb 2026 | See Footnote | ||
| Foresite Capital Management IV, LLC | EIKN | Series C-1 Preferred Stock | Conversion of derivative security | -100% | -785,611 | 0 | 04 Feb 2026 | See Footnote | ||
| Foresite Capital Management IV, LLC | EIKN | Series C Preferred Stock | Conversion of derivative security | -100% | -19,001 | 0 | 04 Feb 2026 | See Footnote | ||
| Foresite Capital Management IV, LLC | EIKN | Series B-1 Preferred Stock | Conversion of derivative security | -100% | -3,895,143 | 0 | 04 Feb 2026 | See Footnote | ||
| Foresite Capital Management IV, LLC | EIKN | Series A-1 Preferred Stock | Conversion of derivative security | -100% | -10,309,278 | 0 | 04 Feb 2026 | See Footnote | ||
| Foresite Capital Management IV, LLC | EIKN | Series A Preferred Stock | Conversion of derivative security | -100% | -10,000,000 | 0 | 04 Feb 2026 | See Footnote | ||
| Kenneth C. Frazier | EIKN | Common Stock | Purchase | 111,111 | 111,111 | 04 Feb 2026 | Direct | |||
| Josh Wolfe | EIKN | Common Stock | Purchase | 277,776 | 138,888 | 04 Feb 2026 | See footnote | |||
| Lux Venture Partners V, LLC | EIKN | Common Stock | Purchase | 277,776 | 138,888 | 04 Feb 2026 | See Footnote |
* marks a reported price that did not pass the local price check.